Chemoinformaics analysis of TRANS-CONIFERYL-DIACETATE
| Molecular Weight | 264.277 | nRot | 5 |
| Heavy Atom Molecular Weight | 248.149 | nRig | 9 |
| Exact Molecular Weight | 264.1 | nRing | 1 |
| Solubility: LogS | -2.539 | nHRing | 0 |
| Solubility: LogP | 1.959 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 35 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 19 | No. of Aromatic Carbocycles | 1 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 14 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 6 |
| nHA | 5 | APOL | 38.0587 |
| nHD | 0 | BPOL | 22.9953 |
| QED | 0.602 |
| Synth | 2.121 |
| Natural Product Likeliness | 0.798 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.99 |
| Pgp-sub | 0.001 |
| HIA | 0.008 |
| CACO-2 | -4.615 |
| MDCK | 0.0000349 |
| BBB | 0.996 |
| PPB | 0.625079 |
| VDSS | 0.646 |
| FU | 0.551823 |
| CYP1A2-inh | 0.957 |
| CYP1A2-sub | 0.136 |
| CYP2c19-inh | 0.484 |
| CYP2c19-sub | 0.362 |
| CYP2c9-inh | 0.123 |
| CYP2c9-sub | 0.8 |
| CYP2d6-inh | 0.03 |
| CYP2d6-sub | 0.687 |
| CYP3a4-inh | 0.251 |
| CYP3a4-sub | 0.4 |
| CL | 5.853 |
| T12 | 0.906 |
| hERG | 0.011 |
| Ames | 0.065 |
| ROA | 0.145 |
| SkinSen | 0.964 |
| Carcinogencity | 0.676 |
| EI | 0.693 |
| Respiratory | 0.46 |
| NR-Aromatase | 0.029 |
| Antiviral | Yes |
| Prediction | 0.790188 |